<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04857021</url>
  </required_header>
  <id_info>
    <org_study_id>AP-PV-2018-01</org_study_id>
    <nct_id>NCT04857021</nct_id>
  </id_info>
  <brief_title>Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Study to Investigate the Sleep Quality Enhancing Effect and Safety of Lactobacillus-fermented GABA in Subjects With Mild, Transient Sleep Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amorepacific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amorepacific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy and safety of dietary supplement&#xD;
      GABA in subjects with mild, transient sleep disorder.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The subjects will take GABA or placebo capsule once daily before sleep for 14 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 14, 2019</start_date>
  <completion_date type="Actual">June 15, 2021</completion_date>
  <primary_completion_date type="Actual">February 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of total sleep time of polysomnography</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>total sleep time(minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of sleep latency of polysomnography</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>sleep latency(minutes)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of sleep efficiency of polysomnography</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>sleep efficiency(percent)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of NonREM stage3 of polysomnography</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>NonREM stage3(mintues)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of total wake time of polysomnography</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>total wake time(mintues)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of wake after sleep onset of polysomnography</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>wake after sleep onset(mintues)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Pittsburgh Sleep Quality Index</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>Change of Pittsburgh Sleep Quality Index(0-21), higher score means worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Insomnia Severity Index</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>Change of Insomnia Severity Index(0-28), higher score means worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Epworth sleepiness scale</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>Change of Epworth sleepiness scale(0-24), higher score means worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Fatigue Severity Scale</measure>
    <time_frame>Baseline, Week 2</time_frame>
    <description>Change of Fatigue Severity Scale(9-63), higher score means worse outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Sleep Disturbance</condition>
  <arm_group>
    <arm_group_label>GABA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Take GABA capsule once daily before sleep for 14 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Take placebo capsule once daily before sleep for 14 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>GABA</intervention_name>
    <description>oral administration of GABA capsule once daily before sleep</description>
    <arm_group_label>GABA</arm_group_label>
    <other_name>Lactobacillus brevis-fermented</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>oral administration of placebo capsule once daily before sleep</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female subjects older than 19 years old&#xD;
&#xD;
          -  Who is experiencing mild, transient sleep disturbance (pittsburgh sleep quality index&#xD;
             ≥ 5, Insomnia Severity Index ≥ 8)&#xD;
&#xD;
          -  Who voluntarily agreed to participate in the study and signed an informed consent&#xD;
             form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Who is suffering from severe sleep disorder including sleep disorders due to&#xD;
             psychological or neurologic causes.&#xD;
&#xD;
          -  Who has used sleeping pills or sleep related dietary supplements within 4 weeks before&#xD;
             study participation&#xD;
&#xD;
          -  Who is suffering from obstructive sleep apnea.&#xD;
&#xD;
          -  Who has used or is expected to inevitably use prohibited concomitant medications&#xD;
             during the study.&#xD;
&#xD;
          -  Women who is pregnant /breast-feeding, or who has childbearing potential and does not&#xD;
             use available contraceptives.&#xD;
&#xD;
          -  Who has dosed other study medications within 30 days before screening.&#xD;
&#xD;
          -  Who is determined ineligible for study participation by investigators for any other&#xD;
             reasons.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kyunghee University Hospital at Gangdong</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

